Titan Pharmaceuticals Inc. (TTNP)
Market Open
16 Dec, 18:46
NASDAQ (CM) NASDAQ (CM) Primary $
2. 34
-0.3
-11.3636%
$
3.11M Market Cap
- P/E Ratio
- Div Yield
131,904 Volume
0 Eps
$ 2.64
Previous Close Investors:
Want to track TTNP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | 100.8 | 99 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 9.9 |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | 69.3 |
| | | - | - |
TTNP Earnings Reports FAQ
What is the earnings per share (EPS) for TTNP?
The current EPS is 0.
What is the company's earnings growth rate?
Over the past 12 years, the earnings growth rate has been approximately 12.62%, reflecting the TTNP's performance and NASDAQ (CM) market conditions.
When is the next earnings release date?
Titan Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Titan Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for TTNP at this time, as Titan Pharmaceuticals Inc has no recent EPS data to calculate it.
